Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

ADTRAN Revenue Surges 20% in Q4

Adtran Holdings, Inc. has reported its unaudited financial results for the fourth quarter ended December 31, 2025. The company's revenue stood at $291.6 million, marking a 20.1% increase year-over-year. The GAAP gross margin was reported at 39.0%, while the non-GAAP gross margin was 42.5%, representing respective increases of 213 and 122 basis points year-over-year.

Additionally, the GAAP operating margin was 1.5%, while the non-GAAP operating margin was 6.4%. The company reported net cash provided by operating activities of $42.2 million and cash and cash equivalents of $95.7 million.

In terms of earnings per share, Adtran Holdings reported a GAAP diluted loss per share of $0.02, whereas the non-GAAP diluted earnings per share stood at $0.16.

Looking forward to 2026, the company provided its business outlook for the first quarter, expecting revenue to be within a range of $275.0 million to $295.0 million, with the non-GAAP operating margin expected to be within a range of 4.0% to 8.0%.

Adtran Holdings' Chairman and CEO, Tom Stanton, highlighted the company's strong fourth-quarter performance with revenue surpassing expectations and growth across all revenue categories. Stanton also emphasized the company's priorities for 2026, focusing on expanding operating margin, cash generation, and capitalizing on customer opportunities.

The company announced it will hold a conference call to discuss its fourth-quarter and full-year 2025 results on Thursday, February 26, 2026, at 7:30 a.m. Central Time.

This article was created using OpenAI. Today the company's shares have moved 1.76% to a price of $9.25. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS